These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36273153)

  • 1. Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin.
    Caracciolo D; Juli G; Riillo C; Coricello A; Vasile F; Pollastri S; Rocca R; Scionti F; Polerà N; Grillone K; Arbitrio M; Staropoli N; Caparello B; Britti D; Loprete G; Costa G; Di Martino MT; Alcaro S; Tagliaferri P; Tassone P
    J Transl Med; 2022 Oct; 20(1):482. PubMed ID: 36273153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation.
    Simsek D; Brunet E; Wong SY; Katyal S; Gao Y; McKinnon PJ; Lou J; Zhang L; Li J; Rebar EJ; Gregory PD; Holmes MC; Jasin M
    PLoS Genet; 2011 Jun; 7(6):e1002080. PubMed ID: 21655080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair.
    Simsek D; Furda A; Gao Y; Artus J; Brunet E; Hadjantonakis AK; Van Houten B; Shuman S; McKinnon PJ; Jasin M
    Nature; 2011 Mar; 471(7337):245-8. PubMed ID: 21390132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair.
    Gao Y; Katyal S; Lee Y; Zhao J; Rehg JE; Russell HR; McKinnon PJ
    Nature; 2011 Mar; 471(7337):240-4. PubMed ID: 21390131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-22 suppresses DNA ligase III addiction in multiple myeloma.
    Caracciolo D; Di Martino MT; Amodio N; Morelli E; Montesano M; Botta C; Scionti F; Talarico D; Altomare E; Gallo Cantafio ME; Zuccalà V; Maltese L; Todoerti K; Rossi M; Arbitrio M; Neri A; Tagliaferri P; Tassone P
    Leukemia; 2019 Feb; 33(2):487-498. PubMed ID: 30120376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of the DNA ligases encoded by the mammalian LIG3 gene.
    Tomkinson AE; Sallmyr A
    Gene; 2013 Dec; 531(2):150-7. PubMed ID: 24013086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA ligase is dispensable for the viability of cultured cells but essential for mtDNA maintenance.
    Shokolenko IN; Fayzulin RZ; Katyal S; McKinnon PJ; Wilson GL; Alexeyev MF
    J Biol Chem; 2013 Sep; 288(37):26594-605. PubMed ID: 23884459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia.
    Sharma NK; Lebedeva M; Thomas T; Kovalenko OA; Stumpf JD; Shadel GS; Santos JH
    DNA Repair (Amst); 2014 Jan; 13():22-31. PubMed ID: 24342190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.
    Muvarak N; Kelley S; Robert C; Baer MR; Perrotti D; Gambacorti-Passerini C; Civin C; Scheibner K; Rassool FV
    Mol Cancer Res; 2015 Apr; 13(4):699-712. PubMed ID: 25828893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative Okazaki Fragment Ligation Pathway by DNA Ligase III.
    Arakawa H; Iliakis G
    Genes (Basel); 2015 Jun; 6(2):385-98. PubMed ID: 26110316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.
    Hu Y; Lin J; Fang H; Fang J; Li C; Chen W; Liu S; Ondrejka S; Gong Z; Reu F; Maciejewski J; Yi Q; Zhao JJ
    Leukemia; 2018 Oct; 32(10):2250-2262. PubMed ID: 29632340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ligases I and III cooperate in alternative non-homologous end-joining in vertebrates.
    Paul K; Wang M; Mladenov E; Bencsik-Theilen A; Bednar T; Wu W; Arakawa H; Iliakis G
    PLoS One; 2013; 8(3):e59505. PubMed ID: 23555685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligase I and ligase III mediate the DNA double-strand break ligation in alternative end-joining.
    Lu G; Duan J; Shu S; Wang X; Gao L; Guo J; Zhang Y
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1256-60. PubMed ID: 26787905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis.
    Bian R; Dang W; Song X; Liu L; Jiang C; Yang Y; Li Y; Li L; Li X; Hu Y; Bao R; Liu Y
    Int J Biol Sci; 2021; 17(9):2167-2180. PubMed ID: 34239347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked contribution of alternative end-joining to chromosome-translocation-formation by stochastically induced DNA double-strand-breaks in G2-phase human cells.
    Soni A; Siemann M; Pantelias GE; Iliakis G
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():2-8. PubMed ID: 26520366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disconnecting XRCC1 and DNA ligase III.
    Katyal S; McKinnon PJ
    Cell Cycle; 2011 Jul; 10(14):2269-75. PubMed ID: 21636980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biallelic variants in LIG3 cause a novel mitochondrial neurogastrointestinal encephalomyopathy.
    Bonora E; Chakrabarty S; Kellaris G; Tsutsumi M; Bianco F; Bergamini C; Ullah F; Isidori F; Liparulo I; Diquigiovanni C; Masin L; Rizzardi N; Cratere MG; Boschetti E; Papa V; Maresca A; Cenacchi G; Casadio R; Martelli P; Matera I; Ceccherini I; Fato R; Raiola G; Arrigo S; Signa S; Sementa AR; Severino M; Striano P; Fiorillo C; Goto T; Uchino S; Oyazato Y; Nakamura H; Mishra SK; Yeh YS; Kato T; Nozu K; Tanboon J; Morioka I; Nishino I; Toda T; Goto YI; Ohtake A; Kosaki K; Yamaguchi Y; Nonaka I; Iijima K; Mimaki M; Kurahashi H; Raams A; MacInnes A; Alders M; Engelen M; Linthorst G; de Koning T; den Dunnen W; Dijkstra G; van Spaendonck K; van Gent DC; Aronica EM; Picco P; Carelli V; Seri M; Katsanis N; Duijkers FAM; Taniguchi-Ikeda M; De Giorgio R
    Brain; 2021 Jun; 144(5):1451-1466. PubMed ID: 33855352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of mammalian DNA ligases.
    Tomkinson AE; Mackey ZB
    Mutat Res; 1998 Feb; 407(1):1-9. PubMed ID: 9539976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low levels of DNA ligases III and IV sufficient for effective NHEJ.
    Windhofer F; Wu W; Iliakis G
    J Cell Physiol; 2007 Nov; 213(2):475-83. PubMed ID: 17492771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ligase III and DNA ligase IV carry out genetically distinct forms of end joining in human somatic cells.
    Oh S; Harvey A; Zimbric J; Wang Y; Nguyen T; Jackson PJ; Hendrickson EA
    DNA Repair (Amst); 2014 Sep; 21():97-110. PubMed ID: 24837021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.